The emergence and dissemination of colistin resistance in Enterobacteriaceae mediated by
plasmid-borne mcr genes in recent years now pose a threat to public health. In this study, we …

Colistin is used to treat infectious diseases in humans and livestock; it has also been used
as a feed additive for livestock for approximately 50 years. Since the mcr-1 plasmid …

The emergence of the plasmid-mediated colistin resistance gene mcr-1 is threatening the
last-line role of colistin in human medicine. With mcr-1-positive Escherichia coli (E. coli) …

Antimicrobial resistance to colistin has emerged worldwide threatening the efficacy of one of
the last-resort antimicrobials used for the treatment of multidrug-resistant Enterobacteriacea …

The global dissemination of colistin resistance has received a great deal of attention.
Recently, the plasmid-mediated colistin resistance encoded by mcr genes in Escherichia …

The objective of this study was to determine the minimal inhibitory concentration of colistin
for Escherichia coli from food animals and the possible underlying colistin resistance …

Abstract Objectives In November 2015, a plasmid-mediated colistin resistance, MCR-1, was
described in animals, food and humans in China, and it was considered as a potential …

Objectives This study investigated the prevalence and characteristics of mcr-1-harbouring
Escherichia coli isolated from chickens in central China from 2014 to 2019. Methods A total …

Introduction The global emergence of plasmid-mediated colistin resistance is threatening
the efficacy of colistin as one of the last treatment options against multi-drug resistant Gram …

Colistin is the last line of defense for the treatment of multidrug-resistant gram-negative
bacterial infections. However, colistin resistance is gradually increasing worldwide, with …